Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Effects of Postconditioning On Myocardial Reperfusion
Not Applicable
Completed
- Conditions
- Myocardial ReperfusionMyocardial Infarction
- Interventions
- Procedure: Post-conditioning
- First Posted Date
- 2009-07-21
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 700
- Registration Number
- NCT00942500
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy Study of Cilostazol Loading in Elective Percutaneous Coronary Intervention
Phase 4
- Conditions
- Angioplasty, Transluminal, Percutaneous Coronary
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2009-07-21
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 400
- Registration Number
- NCT00938522
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide Scanning
Not Applicable
- Conditions
- Continuous Antidepressant AbuseAdverse Reaction to DrugDepression
- Interventions
- First Posted Date
- 2009-07-08
- Last Posted Date
- 2015-12-31
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 202
- Registration Number
- NCT00935246
- Locations
- 🇰🇷
Samsung Medical Center, Kangnam, Seoul, Korea, Republic of
The Impact of Gynecological Surgery on Ovarian Function in Women of Reproductive Age: Postoperative Changes of Serum Anti-Müllerian Hormone (AMH)
- Conditions
- Ovarian ReserveGynecologic OperationsAnti-Mullerian Hormone
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2009-06-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 330
- Registration Number
- NCT00928044
Clinical Characteristics of Patients Under the Age 21 Years Who Underwent Gynecological Surgery
- Conditions
- Demographic FindingsPresenting Symptoms on First Hospital VisitPreoperative Radiologic FindingsOperation MethodHistologic Findings
- First Posted Date
- 2009-06-25
- Last Posted Date
- 2009-06-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 494
- Registration Number
- NCT00928369
Combination Treatment With Doxazosin Plus TolterodineSR 2 mg Versus 4mg in Men With an Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
Phase 4
Completed
- Conditions
- Benign Prostatic HyperplasiaOveractive Bladder
- Interventions
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 83
- Registration Number
- NCT00922506
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome
Not Applicable
Completed
- Conditions
- Chronic ProstatitisChronic Pelvic Pain Syndrome
- Interventions
- Device: Electromagnetic Stimulation Therapy
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2011-05-12
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00922012
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia
Not Applicable
Completed
- Conditions
- Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia
- Interventions
- Procedure: photoselective vaporization prostatectomy (PVP)Procedure: Transurethral resection of the prostate
- First Posted Date
- 2009-05-25
- Last Posted Date
- 2009-05-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 86
- Registration Number
- NCT00908427
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder Patients
Phase 4
Completed
- Conditions
- Overactive Bladder
- Interventions
- Drug: Antimuscarinics
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2010-08-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00902421
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder
Phase 4
Completed
- Conditions
- Overactive Bladder
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-05-15
- Last Posted Date
- 2009-05-15
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 264
- Registration Number
- NCT00903045
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath